Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000899243-22-002025

Director bought 455,000 shares at an average $1.00 ($452,768)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ARMISTICE CAPITAL, LLC Director 2022-01-12 Purchase +57,300 $1.04 $59,781 45,702,300 I: show line 1 in the form
ARMISTICE CAPITAL, LLC Director 2022-01-13 Purchase +312,700 $1.00 $314,013 46,015,000 I: show line 2 in the form
ARMISTICE CAPITAL, LLC Director 2022-01-14 Purchase +85,000 $0.93 $78,974 46,100,000 I: show line 3 in the form
Open-market purchases · 455,000 sh · avg $1.00 · $452,768
Loading xslF345X03/doc4.xml…